查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2015151

神經刺激設備市場：2026-2032年全球市場預測（依產品類型、材料類型、電源、技術、年齡層、應用、最終用戶和通路分類）

Neurostimulation Device Market by Product Type, Material Type, Power Source, Technology, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，神經刺激設備市值將達到 73.9 億美元，到 2026 年將成長到 82.6 億美元，到 2032 年將達到 166.4 億美元，複合年成長率為 12.27%。

主要市場統計數據
基準年 2025 73.9億美元
預計年份：2026年 82.6億美元
預測年份 2032 166.4億美元
複合年成長率 (%) 12.27%

在當今世界，數以百萬計的人飽受神經系統疾病和感覺障礙的折磨，神經刺激設備應運而生，成為一項突破性的解決方案。這些技術能夠將定向電脈衝傳遞至特定的神經通路，從而促進功能恢復並緩解慢性疾病。從恢復聽力的人工電子耳到改變帕金森氏症患者生活的深部腦部刺激器，神經刺激技術始終處於醫療創新的前沿。

本執行摘要了影響神經刺激設備市場的最重要趨勢。它簡潔地概述了該行業的演變，重點介紹了推動市場普及的因素、製造商面臨的挑戰以及可掌握的機會。包括設備開發商、醫療保健專業人員、投資者和監管機構相關人員將清晰了解新興趨勢、策略挑戰和競爭格局。

透過整合產業關鍵人物的觀點、監管文件和技術藍圖，本文檔為決策者提供應對複雜局面所需的知識。無論是研發、打入市場策略或合作機會，本概述都為深入探討塑造神經刺激療法未來發展的關鍵主題奠定了基礎。

了解正在重塑神經刺激領域格局的變革性變化：新技術進步、監管趨勢和臨床實踐。

過去十年，材料科學、裝置小型化和數位化整合技術的進步徹底改變了神經刺激療法領域。植入式刺激器如今配備了封閉回路型回饋系統，能夠即時調整治療方案，從而提高療效並減少副作用。同時，電池技術的創新延長了設備的使用壽命，而無線連接選項則可透過雲端對應平臺實現遠端監控和個人化調整。

分析 2025 年美國關稅政策對神經刺激器供應鏈、成本和競爭力的累積影響。

美國2025年實施的新關稅措施導致進口金屬生物材料、電子元件以及用於神經刺激設備的某些聚合物材料被加徵關稅。製造商面臨採購成本增加的困境，其影響波及整個供應鏈，迫使他們重新調整籌資策略和與海外供應商的合約條款。因此，生產預算不得不重新分配以彌補新增的關稅成本，進一步擠壓產品價格和利潤空間。

從神經刺激市場的產品材料、世代、應用和最終用戶等方面得出的關鍵細分見解。

對細分市場的詳細分析揭示了多個方面微妙的成長軌跡。從產品類型來看，人工電子耳憑藉著不斷擴大的適應症保持著強勁的產品線，而脊髓刺激設備和迷走神經刺激設備在慢性疼痛和癲癇治療領域正迅速獲得市場認可。在材料領域，金屬生物材料因其良好的生物相容性而繼續佔據主導地位，但聚合物基替代品也因其柔軟性和成本效益而備受關注。

確定美洲、歐洲、中東和非洲以及亞太地區神經刺激領域推動成長機會和採用模式的關鍵區域趨勢。

區域分析揭示了成熟曲線和應用模式的差異。在美洲，美國憑藉著高報銷率和積極的臨床試驗活動主導，而加拿大在其公共醫療保健體系下正穩步推進相關技術的應用。在拉丁美洲，成長並不均衡，主要得益於都市區對先進醫療基礎設施的投資，但這種成長動能受到小規模經濟體預算限制的限制。

揭示塑造神經刺激技術和臨床解決方案未來的主要參與者的關鍵策略舉措和產品組合發展。

競爭格局由成熟的全球領導者和敏捷的創新者共同塑造。領先的醫療設備公司不斷透過策略收購專業Start-Ups和與科技公司建立合作關係，拓展其神經調控產品組合。近期，一家電生理學先驅企業與一家數位健康公司合作，創建了一個結合封閉回路型刺激和遠端分析的平台，旨在改善患者療效並支持臨床決策。

制定切實可行的策略建議，幫助產業領導者加速創新應用、最佳化營運並鞏固市場地位。

行業領導者應優先投資於下一代材料，以提高設備小型化程度和患者舒適度，同時保持其電氣性能。與學術機構和受託研究機構(CRO) 進行合作研發，將加速概念驗證(PoC) 研究，並最終開發出新的適應症。此外，企業還需要透過雙源協議和發展區域製造地來實現供應鏈多元化，以應對地緣政治因素和關稅帶來的衝擊。

提出一個全面的研究框架，包括與神經刺激療法相關的調查方法、資料收集方法和分析過程。

本分析的研究框架結合了定性和定量調查方法，以確保研究的嚴謹性和可靠性。研究人員對神經科、生物醫學工程師、供應鏈經理和保險公司代表進行了訪談，以收集關於未滿足的臨床需求、生產挑戰和報銷障礙的第一手觀點。這些訪談結果與從監管文件、同行評審期刊和會議論文集中獲得的二手資料進行了交叉核對和檢驗。

透過整合策略洞察，闡明神經刺激市場的現狀和未來前景，我們將得出全面的結論。

透過整合技術進步、監管趨勢、市場細分和區域部署模式，本分析全面闡述了當前的神經刺激生態系統。主要發現強調了封閉回路型系統和先進生物材料在推動下一代設備性能提升方面的重要性。同時，本分析也考慮了這些技術進步與新關稅和供應鏈重組所帶來的營運挑戰之間的平衡。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：神經刺激設備市場：依產品類型分類

  • 人工電子耳
  • 深層腦部刺激器（DBS）
  • 薦骨神經刺激器（SNS）
  • 脊髓刺激設備（SCS）
  • 迷走神經刺激設備（VNS）

第9章：神經刺激設備市場：依材料類型分類

  • 金屬生物材料
  • 以聚合物為基礎的生物材料

第10章：以電源分類的神經刺激設備市場

  • 不可充電神經刺激設備
  • 可充電神經刺激設備

第11章：神經刺激設備市場：依技術分類

  • 植入式神經刺激設備
  • 非植入式裝置

第12章：神經刺激設備市場：依年齡層別分類

  • 成人版
  • 老年人
  • 兒童

第13章：神經刺激設備市場：依應用領域分類

  • 消化系統疾病
  • 聽力損失
  • 神經系統疾病
    • 肌張力不全症
    • 癲癇
    • 自發性震顫
    • 帕金森氏症
  • 疼痛管理
    • 癌症疼痛
    • 慢性疼痛
  • 睡眠呼吸中止症
  • 尿失禁/糞便失禁
    • 腸道疾病
    • 膀胱過動症

第14章：神經刺激設備市場：依最終用戶分類

  • 門診手術中心（ASC）
  • 居家醫療
  • 醫院
  • 專科診所

第15章：神經刺激設備市場：依通路分類

  • 離線
  • 線上

第16章：神經刺激設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第17章：神經刺激設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第18章：神經刺激設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第19章：美國神經刺激設備市場

第20章：中國神經刺激設備市場

第21章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Bayer AG
  • Beijing PINS Medical Co.
  • Bioventus Inc.
  • Boston Scientific Corporation
  • Cefaly Technology
  • Curonix LLC.
  • electroCore Inc
  • InCube Labs.
  • Integra LifeSciences Holdings Corporation
  • LivaNova PLC
  • Medtronic PLC
  • MicroTransponder, Inc.
  • Motif Neurotech, Inc.
  • Neurosigma, Inc.
  • Nevro Corporation
  • SceneRay Co., Ltd
  • Soterix Medical, Inc.
  • Stimwave LLC
  • Synapse Biomedical Inc.
Product Code: MRR-036C5CF3B4E1

The Neurostimulation Device Market was valued at USD 7.39 billion in 2025 and is projected to grow to USD 8.26 billion in 2026, with a CAGR of 12.27%, reaching USD 16.64 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.39 billion
Estimated Year [2026] USD 8.26 billion
Forecast Year [2032] USD 16.64 billion
CAGR (%) 12.27%

In an era where neurological disorders and sensory impairments affect millions worldwide, neurostimulation devices have emerged as a groundbreaking solution. These technologies deliver targeted electrical impulses to specific neural pathways, restoring function or alleviating chronic conditions. From cochlear implants that grant the gift of hearing to deep brain stimulators that transform the lives of patients with Parkinson's disease, neurostimulation stands at the cutting edge of medical innovation.

This executive summary distills the most critical developments shaping the landscape of neurostimulation devices. It provides a concise yet comprehensive overview of the industry's evolution, highlighting the forces driving adoption, the challenges confronting manufacturers, and the opportunities waiting to be seized. Stakeholders, including device developers, healthcare providers, investors, and regulatory authorities, will gain clarity on emerging trends, strategic imperatives, and the competitive landscape.

By synthesizing insights from leading industry voices, regulatory documents, and technological roadmaps, this document equips decision-makers with the knowledge required to navigate complexity. Whether your interest lies in research and development, market entry strategies, or partnership opportunities, this introduction sets the stage for a deeper exploration of the themes that will define the future of neurostimulation.

Understanding Transformational Shifts Reshaping the Neurostimulation Landscape: Emerging Technological Advances Regulatory Trends and Clinical Practices

Over the past decade, the neurostimulation landscape has been revolutionized by advances in materials science, device miniaturization, and digital integration. Implantable stimulators now incorporate closed-loop feedback systems that adapt therapy in real time, enhancing efficacy and reducing side effects. Concurrently, battery innovations have extended device longevity, while wireless connectivity options enable remote monitoring and personalized adjustments through cloud-enabled platforms.

Regulatory frameworks have evolved in tandem. Expedited review pathways and breakthrough device designations in the United States have accelerated approval times for novel therapies, while the European Union's Medical Device Regulation has raised the bar for clinical evidence and post-market surveillance. This regulatory convergence fosters greater global harmonization but also intensifies the demand for rigorous clinical validation and robust risk management.

Clinical practice guidelines are shifting as well. Physicians are increasingly adopting neuromodulation for off-label applications, driven by compelling real-world evidence. Reimbursement models have adapted to recognize the long-term cost savings associated with reduced medication use and hospital readmissions. Altogether, these transformational shifts are redefining the competitive imperatives for all stakeholders and creating new pathways for patient-centric innovation.

Analyzing the Cumulative Effects of 2025 United States Tariff Policies on Neurostimulation Device Supply Chains Costs and Competitive Positioning

The introduction of new tariff measures by the United States in 2025 has imposed additional duties on imported metallic biomaterials, electronic components, and certain polymeric supplies used in neurostimulation devices. Manufacturers face elevated procurement costs that cascade through the supply chain, prompting a reassessment of sourcing strategies and contract terms with overseas suppliers. As a result, production budgets have been reallocated to cover incremental tariff expenses, adding pressure on product pricing and profit margins.

In response, many firms have turned to nearshoring initiatives, relocating critical manufacturing steps to repatriated facilities within North America. This shift not only mitigates tariff burdens but also reduces logistical risks and lead times. To sustain cost competitiveness, device companies are engaging in proactive negotiations with strategic vendors and exploring alternative material formulations to hedge against duty fluctuations.

Despite these challenges, the industry has demonstrated resilience. Collaborative partnerships between raw material providers and device manufacturers have yielded joint cost-containment programs. Operational teams have optimized inventory management and streamlined customs processes. While the immediate impact manifested as temporary price adjustments, these collective efforts have laid the groundwork for a more agile and tariff-resilient supply chain moving forward.

Deriving Critical Segmentation Insights from Product Material Power Age Application and End User Dimensions in Neurostimulation Markets

A deep dive into the segmentation landscape reveals nuanced growth trajectories across multiple dimensions. When evaluating product type, cochlear implants maintain a robust pipeline driven by expanding indications, while spinal cord stimulators and vagus nerve stimulators show accelerated uptake in chronic pain and epilepsy management. Within the material realm, metallic biomaterials continue to dominate due to their proven biocompatibility, yet polymeric alternatives are gaining traction for their flexibility and cost efficiency.

Power source distinctions also shape market dynamics. Rechargeable neurostimulators are favored for their longevity and reduced need for surgical replacement, whereas non-rechargeable devices maintain stable demand in applications with limited power requirements. Implantable systems command a premium position, leveraging invasive techniques for targeted therapy, but non-implantable technologies are expanding access through wearable stimulators for conditions like sleep apnea.

Demographic factors further refine opportunity zones. Pediatric patients represent a specialized segment where device miniaturization and safety protocols are paramount, while geriatric populations drive demand in chronic pain and movement disorder treatments. In adult cohorts, applications span gastrointestinal disorders to urinary and fecal incontinence. Neurological disorder sub-segments such as dystonia, epilepsy, essential tremor, and Parkinson's disease present distinct clinical needs, as do pain management subdivisions focusing on cancer and chronic pain. End-user environments range from ambulatory surgery centers to home healthcare settings, with specialty clinics serving as centers of excellence. Offline channels remain the predominant route to market, though online platforms are emerging for post-market device support and remote programming services.

Unveiling Key Regional Dynamics Driving Growth Opportunities and Adoption Patterns across Americas EMEA and Asia Pacific Neurostimulation Sectors

Regional evaluation uncovers differing maturity curves and adoption patterns. In the Americas, the United States leads with high reimbursement rates and strong clinical trial activity, while Canada shows steady uptake under public healthcare frameworks. Latin America exhibits variable growth, propelled by urban centers that invest in advanced medical infrastructure, albeit tempered by budget constraints in smaller economies.

Within Europe, Middle East & Africa, Western European markets benefit from harmonized regulatory pathways and established neuromodulation programs, whereas Eastern European regions are gradually integrating advanced devices into public systems. The Middle East is characterized by government-funded healthcare initiatives that prioritize flagship hospitals, and Africa's market remains nascent, driven by select private facilities in urban hubs.

Asia-Pacific presents a dual narrative: Japan's well-funded research ecosystem and aging population fuel innovation and demand, while China's domestic players intensify competition through localized manufacturing and price-competitive offerings. In India and Southeast Asia, government investments in healthcare infrastructure and rising disposable incomes are unlocking new patient pools. Across these regions, digital health integration and telemedicine frameworks are rapidly evolving, facilitating remote patient monitoring and expanding the reach of neuromodulation therapies.

Illuminating Leading Strategic Moves and Portfolio Developments from Key Players Shaping the Future of Neurostimulation Technology and Clinical Solutions

The competitive landscape is shaped by established global leaders and agile innovators. Major medical device corporations continue to expand their neuromodulation portfolios through strategic acquisitions of specialist startups and partnerships with technology firms. Recent collaborations between electrophysiology pioneers and digital health companies have produced platforms that combine closed-loop stimulation with remote analytics, enhancing patient outcomes and clinical decision support.

Several players have advanced high-frequency stimulation modalities, targeting specific neuronal pathways with unprecedented precision. Others are developing next-generation electrode arrays with bioactive coatings to minimize fibrotic responses. Concurrently, emerging companies are introducing cost-effective non-implantable stimulators aimed at home-based applications, democratizing access for broader patient populations.

Leadership is increasingly defined by the ability to integrate multidisciplinary expertise-from neuroscience and materials engineering to software development and data analytics. Firms that demonstrate agility in navigating regulatory submissions, securing reimbursement coding, and scaling manufacturing will be best positioned to capitalize on the expanding neurostimulation market. Portfolio breadth, coupled with clinical evidence generation, remains the cornerstone of sustainable competitive advantage.

Formulating Actionable Strategic Recommendations to Help Industry Leaders Accelerate Innovation Adoption Optimize Operations and Strengthen Market Positioning

Industry leaders should prioritize investment in next-generation materials that reduce device profile and enhance patient comfort while maintaining electrical performance. Collaborative R&D alliances with academic institutions and contract research organizations will accelerate proof-of-concept studies and unlock novel indications. Companies must also diversify supply reservoirs by establishing dual-source agreements and exploring regional manufacturing hubs to buffer against geopolitical and tariff-related disruptions.

Engaging proactively with regulatory bodies can streamline approval processes; early dialogue regarding clinical trial design and risk-benefit analyses will mitigate uncertainties. Payers and providers should be engaged through value-based contracting models that align reimbursement with long-term patient outcomes. Training programs for surgeons and allied health professionals will support adoption of complex implantable systems, while digital literacy initiatives will increase patient acceptance of remote monitoring tools.

Finally, embracing data-driven service offerings-such as predictive maintenance of implantable devices and AI-powered therapy optimization-will create recurring revenue streams and strengthen customer loyalty. By executing these actionable recommendations, organizations can chart a course toward sustained innovation and commercial success in the evolving neurostimulation arena.

Articulating a Comprehensive Research Framework Including Methodological Approaches Data Collection Techniques and Analytical Processes for Neurostimulation

The research framework underpinning this analysis combines qualitative and quantitative methodologies to ensure rigor and reliability. Primary interviews were conducted with neurologists, biomedical engineers, supply chain directors, and payer representatives to gather firsthand perspectives on unmet clinical needs, manufacturing challenges, and reimbursement hurdles. These insights were triangulated with secondary data sourced from regulatory filings, peer-reviewed journals, and conference proceedings.

Material supply chain mapping employed trade data and customs records to identify key suppliers of metallic and polymeric biomaterials, while device shipment analytics highlighted regional distribution trends. Technology assessment drew upon patent landscape evaluations and product registries to track innovation trajectories in implantable and non-implantable devices. Clinical trial databases were mined to quantify study volumes across applications ranging from gastrointestinal disorders to movement disorders.

Analytical processes included scenario modeling to assess the impact of tariff adjustments and statistical clustering to uncover latent segmentation patterns. Data validation protocols were implemented through cross-referencing multiple independent sources, and an internal review board oversaw quality control measures. This comprehensive methodology ensures that the findings presented herein rest upon a robust evidentiary foundation, offering decision-makers a high degree of confidence in strategic planning and investment decisions.

Drawing Holistic Conclusions by Synthesizing Strategic Findings to Illuminate the Neurostimulation Market's Current State and Anticipated Future Trajectory

By synthesizing technological trajectories, regulatory developments, market segmentation, and regional adoption patterns, this analysis offers a holistic understanding of the current neurostimulation ecosystem. Key takeaways emphasize the importance of closed-loop systems and advanced biomaterials in driving next-generation device performance, balanced against the operational imperatives imposed by new tariff measures and supply chain realignments.

Segmentation insights highlight that cochlear implants and spinal cord stimulators will continue to anchor the market, even as emerging applications in gastrointestinal and urinary disorders unlock new growth corridors. Regional dynamics underscore the United States and Western Europe as early adopters, while Asia-Pacific and select Latin American markets present rapid expansion potential underpinned by healthcare investments and demographic shifts.

Competitive positioning will hinge on the ability to deliver clinically validated, patient-centric solutions at scale. Firms that effectively integrate cross-disciplinary expertise, leverage digital health platforms for remote care, and forge resilient supply networks will lead the charge. This conclusion sets the stage for executives to refine their strategic roadmaps and capitalize on the untapped opportunities across the multifaceted neurostimulation landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurostimulation Device Market, by Product Type

  • 8.1. Cochlear Implants
  • 8.2. Deep Brain Stimulators (DBS)
  • 8.3. Sacral Nerve Stimulators (SNS)
  • 8.4. Spinal Cord Stimulators (SCS)
  • 8.5. Vagus Nerve Stimulators (VNS)

9. Neurostimulation Device Market, by Material Type

  • 9.1. Metallic Biomaterials
  • 9.2. Polymeric Biomaterials

10. Neurostimulation Device Market, by Power Source

  • 10.1. Non-Rechargeable Neurostimulators
  • 10.2. Rechargeable Neurostimulators

11. Neurostimulation Device Market, by Technology

  • 11.1. Implantable Neurostimulation Devices
  • 11.2. Non-Implantable Devices

12. Neurostimulation Device Market, by Age Group

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Neurostimulation Device Market, by Application

  • 13.1. Gastrointestinal Disorders
  • 13.2. Hearing Loss
  • 13.3. Neurological Disorders
    • 13.3.1. Dystonia
    • 13.3.2. Epilepsy
    • 13.3.3. Essential Tremor
    • 13.3.4. Parkinson's Disease
  • 13.4. Pain Management
    • 13.4.1. Cancer Pain
    • 13.4.2. Chronic Pain
  • 13.5. Sleep Apnea
  • 13.6. Urinary & Fecal Incontinence
    • 13.6.1. Bowel Disorders
    • 13.6.2. Overactive Bladder

14. Neurostimulation Device Market, by End User

  • 14.1. Ambulatory Surgery Centers (ASCs)
  • 14.2. Home Healthcare
  • 14.3. Hospitals
  • 14.4. Specialty Clinics

15. Neurostimulation Device Market, by Distribution Channel

  • 15.1. Offline
  • 15.2. Online

16. Neurostimulation Device Market, by Region

  • 16.1. Americas
    • 16.1.1. North America
    • 16.1.2. Latin America
  • 16.2. Europe, Middle East & Africa
    • 16.2.1. Europe
    • 16.2.2. Middle East
    • 16.2.3. Africa
  • 16.3. Asia-Pacific

17. Neurostimulation Device Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. Neurostimulation Device Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. United States Neurostimulation Device Market

20. China Neurostimulation Device Market

21. Competitive Landscape

  • 21.1. Market Concentration Analysis, 2025
    • 21.1.1. Concentration Ratio (CR)
    • 21.1.2. Herfindahl Hirschman Index (HHI)
  • 21.2. Recent Developments & Impact Analysis, 2025
  • 21.3. Product Portfolio Analysis, 2025
  • 21.4. Benchmarking Analysis, 2025
  • 21.5. Abbott Laboratories
  • 21.6. Bayer AG
  • 21.7. Beijing PINS Medical Co.
  • 21.8. Bioventus Inc.
  • 21.9. Boston Scientific Corporation
  • 21.10. Cefaly Technology
  • 21.11. Curonix LLC.
  • 21.12. electroCore Inc
  • 21.13. InCube Labs.
  • 21.14. Integra LifeSciences Holdings Corporation
  • 21.15. LivaNova PLC
  • 21.16. Medtronic PLC
  • 21.17. MicroTransponder, Inc.
  • 21.18. Motif Neurotech, Inc.
  • 21.19. Neurosigma, Inc.
  • 21.20. Nevro Corporation
  • 21.21. SceneRay Co., Ltd
  • 21.22. Soterix Medical, Inc.
  • 21.23. Stimwave LLC
  • 21.24. Synapse Biomedical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROSTIMULATION DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 16. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY IMPLANTABLE NEUROSTIMULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY IMPLANTABLE NEUROSTIMULATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY IMPLANTABLE NEUROSTIMULATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 233. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 234. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. GCC NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 267. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 269. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 270. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 271. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. G7 NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 279. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 281. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 282. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 283. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. NATO NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)